Summary of Shareholders Equity Warrants Outstanding (Details) - shares |
12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|||||||||
Equity [Abstract] | ||||||||||
Shares Outstanding, beginning | 5,397,000 | [1] | 5,799,000 | |||||||
Shares Issued | ||||||||||
Shares Exercised | (2,576,000) | [2] | (402,000) | |||||||
Shares Tendered | ||||||||||
Shares Expired | (1,493,000) | |||||||||
Shares Outstanding, ending | 1,328,000 | [3] | 5,397,000 | [1] | ||||||
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments tendered. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|